Physicians at Cleveland Clinic Abu Dhabi have performed the region’s first “POP” procedures, an innovative technique that can alleviate the debilitating symptoms of gastroparesis, a chronic digestive disease.

The non-surgical technique, known as Per Oral Pyloromytomy (POP), is based on techniques pioneered in Japan and is now available at Cleveland Clinic Abu Dhabi, where fourUAE National patients have already undergone the procedure this year.

Gastroparesis, which is also known as delayed gastric emptying or “paralyzed stomach”, is a disease that prevents a patient’s stomach from digesting food and emptying properly. Sufferers experience a range of debilitating symptoms, such as severe nausea, vomiting, heartburn, extreme weight loss, bloating and acid reflux.

While diabetes is one of the main causes of gastroparesis, other illnesses can also cause the disease, such as chronic pancreatitis, cystic fibrosis, kidney disease, Turner’s syndrome and Parkinson’s disease. In some cases, the cause is unknown and can also occur after previous surgical procedures on the stomach.

“Gastroparesis affects millions of people around the world,” said Dr. Matthew Kroh, chief of the Digestive Disease Institute at Cleveland Clinic Abu Dhabi. “In terms of incidence, it is one of the fastest-growing diseases that we are currently treating in the Institute and, with more than one million people suffering from diabetes in the UAE, gastroparesisis a looming disease burden in the future.”

The POP procedure allows physicians to cut the pylorus – the muscular valve that empties the stomach – without surgery. The procedure is performed through the mouth using advanced endoscopic tools and under high-definition vision, which lessens the risk of complications and eliminates the trauma of open surgery.

A 35-year-old male patient suffering from cerebral palsy, a birth-related disorder that affects the brain and nervous system, and multiple medical problems underwent the POP procedure earlier this year, while two patients were women in their 50s suffering from Type 2 diabetes. All four were referred to Cleveland Clinic Abu Dhabi by the Imperial College London Diabetes Centre, part of Mubadala’s network of world-class healthcare providers.

“To be able to manage the full spectrum of care for the three UAE National patients who have suffered with gastroparesis is very rewarding. Giving these patients the support and treatment they really need – and watching them steadily improve – makes it all worthwhile,” concluded Dr. Kroh.

Cleveland Clinic Abu Dhabi’s Digestive Disease Institute leads the way in gastrointestinal care in the region through a range of advanced procedures. These include minimally invasive and robotic bariatric, hernia, gastrointestinal, and colorectal surgeries, as well the treatment of pancreatic,liver, and biliary diseases.


About Cleveland Clinic Abu Dhabi

Cleveland Clinic Abu Dhabi, part of Mubadala’s network of world-class healthcare providers, is a multispecialty hospital on Al Maryah Island in Abu Dhabi, UAE. Cleveland Clinic Abu Dhabi is a unique and unparalleled extension of US-based Cleveland Clinic’s model of care, specifically designed to address a range of complex and critical care requirements unique to the Abu Dhabi population.

Cleveland Clinic Abu Dhabi has the following Institutes: Heart & Vascular, Neurological, Digestive Disease, Eye, Respiratory & Critical Care, Surgical Subspecialties, Medical Subspecialties, Emergency Medicine, Anesthesiology, Pathology & Laboratory Medicine, Imaging, Quality & Patient Safety, and Clinical & Nursing. In all, more than 30 medical and surgical specialties are represented at Cleveland Clinic Abu Dhabi.

The facilities at Cleveland Clinic Abu Dhabi combine state-of-the-art amenities and world-class service standards. The hospital is a 364 (expandable to 490) bed facility, with five clinical floors, three diagnostic and treatment levels, and 13 floors of critical and acute inpatient units. It is a physician-led medical facility served by North American/European Board Certified (or equivalent) physicians. Cleveland Clinic Abu Dhabi provides patients in the region direct access to the world’s best healthcare providers and Cleveland Clinic’s unique model of care, reducing their need to travel abroad for treatment.


Mubadala Investment Company

Mubadala is a pioneering global investor, deploying capital with integrity and ingenuity to accelerate economic growth for the long-term benefit of Abu Dhabi. As Abu Dhabi’s leading strategic investment company, Mubadala is active in 13 sectors and more than 30 countries around the world, creating lasting value for our shareholder, the Government of Abu Dhabi.

Our work includes the development of global industrial champions in sectors such as aerospace, ICT, semiconductors, metals & mining and renewable energy, utilities, and the management of diverse financial holdings. We build on legacy expertise in oil and gas to invest across the hydrocarbon spectrum, and enhance the UAE’s growth potential through investments in healthcare, real estate and defense services. Our investment approach prioritizes partnership with best-in-class organizations and a commitment to the highest standards of governance.


Source: Wallis PR